JP2020189845A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020189845A5 JP2020189845A5 JP2020127888A JP2020127888A JP2020189845A5 JP 2020189845 A5 JP2020189845 A5 JP 2020189845A5 JP 2020127888 A JP2020127888 A JP 2020127888A JP 2020127888 A JP2020127888 A JP 2020127888A JP 2020189845 A5 JP2020189845 A5 JP 2020189845A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- fibrosis
- inhibitor
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022199857A JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2015903035 | 2015-07-30 | ||
| AU2015903035A AU2015903035A0 (en) | 2015-07-30 | Fibrotic treatment | |
| JP2018504650A JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Division JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199857A Division JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020189845A JP2020189845A (ja) | 2020-11-26 |
| JP2020189845A5 true JP2020189845A5 (https=) | 2021-04-01 |
| JP7457360B2 JP7457360B2 (ja) | 2024-03-28 |
Family
ID=57883919
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Withdrawn JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
| JP2020127888A Active JP7457360B2 (ja) | 2015-07-30 | 2020-07-29 | 線維症の処置 |
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018504650A Withdrawn JP2018527330A (ja) | 2015-07-30 | 2016-07-29 | 線維症の処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022199857A Pending JP2023030022A (ja) | 2015-07-30 | 2022-12-15 | 線維症の処置 |
Country Status (8)
| Country | Link |
|---|---|
| US (5) | US10100311B2 (https=) |
| EP (1) | EP3328384B1 (https=) |
| JP (3) | JP2018527330A (https=) |
| AU (1) | AU2016301113B2 (https=) |
| CA (1) | CA3017028C (https=) |
| HK (1) | HK1256423A1 (https=) |
| SG (1) | SG11201808478RA (https=) |
| WO (1) | WO2017015720A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3294721A4 (en) * | 2015-05-08 | 2018-11-07 | Monash University | 4h-pyran compounds as insulin-regulated aminopeptidase (irap) inhibitors |
| JP2018527330A (ja) | 2015-07-30 | 2018-09-20 | モナシュ ユニバーシティー | 線維症の処置 |
| WO2019014710A1 (en) * | 2017-07-17 | 2019-01-24 | Monash University | ANGIOTENSIN RECEPTOR AGONISTS AND USES THEREOF |
| EP3902460A4 (en) * | 2018-12-28 | 2023-01-11 | The General Hospital Corporation | ANTI-EPHRIN B2 BLOCKER ANTIBODIES FOR THE TREATMENT OF FIBROTIC DISEASES |
| WO2021050089A1 (en) * | 2019-09-09 | 2021-03-18 | Washington State University | Genetic test for identifying cats at a high risk for developing tubulointerstitial fibrosis |
| CA3171882A1 (en) | 2020-02-19 | 2021-08-26 | Hepion Pharmaceuticals, Inc. | Use of cyclosporine analogues for treating fibrosis |
| WO2023099589A1 (en) * | 2021-12-01 | 2023-06-08 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Irap inhibitors for use in the treatment of inflammatory diseases |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2403340T3 (es) * | 2004-09-09 | 2013-05-17 | Howard Florey Institute Of Experimental Physiology And Medicine | Inhibidores de aminopeptidasa regulada por insulina (IRAP) y usos de los mismos |
| WO2007024946A2 (en) * | 2005-08-23 | 2007-03-01 | Wyeth | Methods for the treatment of anxiety and for identification of anxiolytic agents |
| EP2262797A4 (en) * | 2007-11-19 | 2011-11-30 | Howard Florey Inst | INHIBITORS OF INSULIN REGULATED AMINO PEPTIDASE (IRAP) AND APPLICATIONS THEREOF |
| CN104302305A (zh) * | 2011-12-16 | 2015-01-21 | 塔瑞克斯制药有限公司 | 用于治疗纤维化的血管紧张素 |
| KR20140127307A (ko) | 2012-02-06 | 2014-11-03 | 글락소스미스클라인 인털렉츄얼 프로퍼티 (넘버 2) 리미티드 | 섬유성 질병을 치료하기 위한 pi3k 억제제 |
| JP6327923B2 (ja) | 2014-04-25 | 2018-05-23 | 旭化成株式会社 | ポリアセタール樹脂組成物、及びそれからなる成形体 |
| DE102014114090A1 (de) | 2014-09-29 | 2016-03-31 | Karlsruher Institut für Technologie | Verfahren zur Abtrennung von Aluminium bei der Calciumsilikatproduktion |
| US9519061B2 (en) * | 2014-12-26 | 2016-12-13 | Here Global B.V. | Geometric fingerprinting for localization of a device |
| EP3294721A4 (en) * | 2015-05-08 | 2018-11-07 | Monash University | 4h-pyran compounds as insulin-regulated aminopeptidase (irap) inhibitors |
| JP2018527330A (ja) * | 2015-07-30 | 2018-09-20 | モナシュ ユニバーシティー | 線維症の処置 |
-
2016
- 2016-07-29 JP JP2018504650A patent/JP2018527330A/ja not_active Withdrawn
- 2016-07-29 EP EP16829507.9A patent/EP3328384B1/en active Active
- 2016-07-29 AU AU2016301113A patent/AU2016301113B2/en active Active
- 2016-07-29 US US15/747,697 patent/US10100311B2/en active Active
- 2016-07-29 CA CA3017028A patent/CA3017028C/en active Active
- 2016-07-29 SG SG11201808478RA patent/SG11201808478RA/en unknown
- 2016-07-29 HK HK18115556.4A patent/HK1256423A1/zh unknown
- 2016-07-29 WO PCT/AU2016/050681 patent/WO2017015720A1/en not_active Ceased
-
2018
- 2018-09-06 US US16/123,898 patent/US10787668B2/en active Active
-
2020
- 2020-07-29 JP JP2020127888A patent/JP7457360B2/ja active Active
- 2020-08-04 US US16/984,996 patent/US11078488B2/en active Active
-
2021
- 2021-07-01 US US17/365,260 patent/US11834663B2/en active Active
-
2022
- 2022-12-15 JP JP2022199857A patent/JP2023030022A/ja active Pending
-
2023
- 2023-10-26 US US18/495,512 patent/US20240084308A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020189845A5 (https=) | ||
| JP2018527330A5 (https=) | ||
| JP6526306B2 (ja) | バルドキソロンメチルまたはその類似体を使用して内皮機能障害を処置および予防する方法 | |
| JP4692281B2 (ja) | 新規アゾール化合物 | |
| JP3187535B2 (ja) | 医薬的に活性なヒドラジン誘導体およびその製造方法 | |
| BR122018015003B1 (pt) | kit compreendendo composições farmacêuticas de inibidor da nep e de valsartan ou seus sais | |
| JP2023030022A5 (https=) | ||
| JP7457360B2 (ja) | 線維症の処置 | |
| JPH09506368A (ja) | 複素環式脱離基を含むシステインプロテアーゼインヒビター | |
| JPWO2007083689A1 (ja) | プラスミノーゲンアクチベーターインヒビター−１阻害剤 | |
| JPH08508720A (ja) | ピロールーアミジン化合物およびその薬剤的に受容できる塩、その製造法ならびにこれを含む医薬組成物 | |
| JP2022513915A (ja) | 新規化合物及びそれらの治療における使用 | |
| JP2021519312A (ja) | カルパインモジュレーター及びその治療的使用 | |
| JP5410278B2 (ja) | βセクレターゼ阻害活性を有する新規化合物 | |
| JPH10130144A (ja) | アルツハイマー病の治療および予防用の医薬を製造するための非ペプチドのブラジキニンアンタゴニストの使用 | |
| JP2003183254A (ja) | ２−アシルアミノ−３，５−ジシアノピリジン誘導体又はその塩 | |
| US20190169185A1 (en) | Substituted 2-n-hydroxy-1,3-dioxo-1,2,3,4-tetrahydronaphthyridines, and methods of making and using same | |
| AU2020402994A1 (en) | Methods of treating cancer | |
| US20050130941A1 (en) | Methods of treating alzheimer's disease | |
| JP2007131532A (ja) | 生体内リン輸送を阻害する化合物およびそれを含んでなる医薬 | |
| JP2023505598A (ja) | 化合物及びα１－アンチトリプシン欠損症の治療のためのそれらの使用 | |
| JP2002544119A (ja) | フェニルアラニン誘導体 | |
| TW201215389A (en) | Sustained-release therapeutic agent for hypertension and renal dysfunction | |
| JPH0529209B2 (https=) | ||
| US20210260153A1 (en) | Use of cyclosporine analogues for treating fibrosis |